Turnover: 123.9 million EUR (2022)
Country: France
Founded in 1978, Laboratoires Filorga's first major innovation was an injectable solution (NTCF) designed to correct age-related skin alterations, a technology that still ensures its position in the field of skin ageing today.
Present in 60 countries, Filorga products have been available to the general public since the launch of its first cosmetics range, Medi-Cosmetics, in 2007.
Filorga focuses on two main markets: cosmetics (particularly anti-aging) and aesthetic medicine.
Indeed, the group has developed a wide range of aesthetic medicine solutions, such as peels, wrinkle fillers (hyaluronic acid), injectable poly-revitalization (NCTF), and photomodulation.
Filorga follows an expansion strategy with the acquisition of SVR in 2014, Le Couvent des Minimes in 2017 and Lazartigue in 2018.
Translated with the translator's free version - www.DeepL.com/Translator
Financial Data
DUNS: 811668003
Legal Name: LABORATOIRES FILORGA COSMETIQUES
Address: 2 RUE DE LISBONNE 2-4, 75008 PARIS 8
Number of employees: Entre 100 et 199 salariés (2021)
Capital: 34 613 505 EUR
Financial Data:
| Year | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Turnover | 123 885 236 | 134 177 480 | 163 808 053 | 215 335 252 |
| Gross margin (€) | 106 119 186 | 102 691 626 | 123 521 712 | 186 791 910 |
| EBITDA (€) | -12 813 329 | -1 060 472 | 23 458 653 | 59 088 571 |
| Operating profit (€) | -16 102 273 | -3 333 478 | 17 287 080 | 58 199 603 |
| Net profit (€) | -15 161 180 | -1 866 603 | 12 374 266 | 40 864 683 |
| Turnover growth rate (%) | -7,7 | -18,1 | -23,9 | 26,9 |
| Ebitda margin rate (%) | -10,3 | -0,8 | 14,3 | 27,4 |
| Operating margin rate (%) | -13 | -2,5 | 10,6 | 27 |
| Working Capital (turnover days) | 94,5 | 139,3 | 195,1 | 77,4 |
| Working Capital requirements (turnover days) | 52,5 | 56,6 | 86,7 | 90,2 |
| Net margin (%) | -12,2 | -1,4 | 7,6 | 19 |
| Added value / Turnover (%) | -1,9 | 9,3 | 22 | 32,7 |
| Wages and social charges (€) | 11 541 888 | 13 443 525 | 10 997 824 | 9 796 502 |
| Salaries / Turnover (%) | 9,3 | 10 | 6,7 | 4,5 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président | Thierry, Eric | Antona-traversi | 54 |
Studies mentioning this company
The aesthetic medicine market - France
Other companies mentioned:
- Allergan plc
- Galderma
- Merz Pharmaceuticals
- La Roche-Posay
- Filorga Cosmétiques (Colgate Palmolive)
- Lierac (Laboratoire Native)
- Laboratoires Sebbin
- Arion
- Candela Medical
- Deleo
- Ipsen
- Clinique des Champs Elysées
- Lazeo
- Maison Lutetia
- Skincareagency
The aesthetic medicine market - Portugal
Other companies mentioned:
- Allergan plc
- La Roche-Posay
- Laboratoires Sebbin
- Arion
- Filorga Cosmétiques (Colgate Palmolive)
> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)
Sector-GPT est la première IA dédiée aux informations sectorielles.